KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Other Accumulated Expenses: 2018-2025

Historic Other Accumulated Expenses for Twist Bioscience (TWST) over the last 8 years, with Sep 2025 value amounting to $12.1 million.

  • Twist Bioscience's Other Accumulated Expenses rose 108.85% to $12.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.1 million, marking a year-over-year increase of 108.85%. This contributed to the annual value of $12.1 million for FY2025, which is 108.85% up from last year.
  • According to the latest figures from FY2025, Twist Bioscience's Other Accumulated Expenses is $12.1 million, which was up 108.85% from $5.8 million recorded in FY2024.
  • In the past 5 years, Twist Bioscience's Other Accumulated Expenses registered a high of $19.7 million during FY2022, and its lowest value of $5.8 million during FY2024.
  • Over the past 3 years, Twist Bioscience's median Other Accumulated Expenses value was $7.8 million (recorded in 2023), while the average stood at $8.6 million.
  • In the last 5 years, Twist Bioscience's Other Accumulated Expenses soared by 268.56% in 2021 and then crashed by 60.47% in 2023.
  • Over the past 5 years, Twist Bioscience's Other Accumulated Expenses (Yearly) stood at $9.6 million in 2021, then spiked by 105.10% to $19.7 million in 2022, then slumped by 60.47% to $7.8 million in 2023, then fell by 25.45% to $5.8 million in 2024, then skyrocketed by 108.85% to $12.1 million in 2025.